Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema

PHASE2TerminatedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Diabetic RetinopathyDiabetes Complications
Interventions
PROCEDURE

Laser Treatment

Necessity of laser treatment is assessed every three months.

DRUG

PF-04523655 high

3 mg intravitreal injection

DRUG

PF-04523655 middle

1 mg intravitreal injection

DRUG

PF-04523655 low

0.4 mg intravitreal injection

Trial Locations (53)

2600

Pfizer Investigational Site, Glostrup Municipality

20122

Pfizer Investigational Site, Milan

20132

Pfizer Investigational Site, Milan

20157

Pfizer Investigational Site, Milan

21287

Pfizer Investigational Site, Baltimore

27157

Pfizer Investigational Site, Winston-Salem

27262

Pfizer Investigational Site, High Point

28210

Pfizer Investigational Site, Charlotte

28677

Pfizer Investigational Site, Statesville

30909

Pfizer Investigational Site, Augusta

33100

Pfizer Investigational Site, Udine

33805

Pfizer Investigational Site, Lakeland

33880

Pfizer Investigational Site, Winter Haven

35128

Pfizer Investigational Site, Padua

44281

Pfizer Investigational Site, Kfar Saba

46290

Pfizer Investigational Site, Indianapolis

47150

Pfizer Investigational Site, New Albany

48145

Pfizer Investigational Site, Münster

49100

Pfizer Investigational Site, Petah Tikva

52621

Pfizer Investigational Site, Tel Litwinsky

57701

Pfizer Investigational Site, Rapid City

60637

Pfizer Investigational Site, Chicago

64239

Pfizer Investigational Site, Tel Aviv

70300

Pfizer Investigational Site, Ẕerifin

78413

Pfizer Investigational Site, Corpus Christi

79106

Pfizer Investigational Site, Freiburg im Breisgau

85014

Pfizer Investigational Site, Phoenix

85016

Pfizer Investigational Site, Phoenix

85210

Pfizer Investigational Site, Mesa

Pfizer Investigational Site, Meza

85381

Pfizer Investigational Site, Peoria

89052

Pfizer Investigational Site, Henderson

89074

Pfizer Investigational Site, Henderson

89109

Pfizer Investigational Site, Las Vegas

94040

Pfizer Investigational Site, Mountain View

96701

Pfizer Investigational Site, ‘Aiea

02111

Pfizer Investigational Site, Boston

02215

Pfizer Investigational Site, Boston

03801

Pfizer Investigational Site, Portsmouth

04103

Pfizer Investigational Site, Leipzig

751 024

Pfizer Investigational Site, Bhubaneshwar

380 004

Pfizer Investigational Site, Ahmedabad

560 085

Pfizer Investigational Site, Bangalore

110 029

Pfizer Investigational Site, New Delhi

00168

Pfizer Investigational Site, Roma

00198

Pfizer Investigational Site, Roma

L27

Pfizer Investigational Site, Lima

GU15 3UW

Pfizer Investigational Site, Frimley

BS1 2LX

Pfizer Investigational Site, Bristol

BS2 8HW

Pfizer Investigational Site, Bristol

L7 8XP

Pfizer Investigational Site, Liverpool

S10 2JF

Pfizer Investigational Site, Sheffield

SO16 6YD

Pfizer Investigational Site, Southampton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Quark Pharmaceuticals

INDUSTRY